You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsing MS

Showing 1 - 25 of 3,089
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Demyelinating Autoimmune Diseases, CNS Trial in Amsterdam

Recruiting
  • Multiple Sclerosis
  • +5 more
  • Amsterdam, Netherlands
    Amsterdam UMC, location VUmc
Apr 17, 2023

Integrated Digital Solutions in Medical Care of Multiple

Not yet recruiting
  • Relapsing Remitting Multiple Sclerosis
  • MS Care Platform (icobrain ms and icompanion ms)
  • (no location specified)
Jul 10, 2023

Multiple Sclerosis Trial in Los Angeles (Blood draw for future biomarker analysis)

Completed
Has Results
  • Multiple Sclerosis
  • Blood draw for future biomarker analysis
  • Los Angeles, California
    Investigational Site Number 8400001
Mar 15, 2022

Multiple Sclerosis Trial in Genova (7-day Fasting-Mimicking Diet (7-DAY FMD))

Active, not recruiting
  • Multiple Sclerosis
  • 7-day Fasting-Mimicking Diet (7-DAY FMD)
  • Genova, Italy
    Ospedale San Martino
Sep 8, 2023

Multiple Sclerosis (MS) Patients

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • +2 more
    • (no location specified)
    Dec 15, 2022

    Relapsing Remitting Multiple Sclerosis Trial in Norway (Rituximab, Ocrelizumab)

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • Bergen, Norway
    • +10 more
    Mar 18, 2022

    Examining Effects of Ocrevus on Cognitive Fatigue Using fMRI

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • West Orange, New Jersey
      Kessler Foundation
    Oct 12, 2022

    Multiple Sclerosis Trial in Amsterdam (MS Sherpa)

    Recruiting
    • Multiple Sclerosis
    • MS Sherpa
    • Amsterdam, Netherlands
      Amsterdam UMC, locatie VUmc
    Nov 4, 2023

    Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

    Not yet recruiting
    • Multiple Sclerosis (MS)
    • +6 more
    • Clemastine Fumarate
    • Placebo
    • San Francisco, California
      Sandler Neurosciences Building, Neurological Clinical Research U
    Jan 23, 2023

    Relapsing Remitting Multiple Sclerosis Trial in Portland (3 mg Melatonin, 5 mg Melatonin)

    Active, not recruiting
    • Relapsing Remitting Multiple Sclerosis
    • 3 mg Melatonin
    • 5 mg Melatonin
    • Portland, Oregon
      Providence MS Center
    May 5, 2022

    Multiple Sclerosis Trial (Natalizumab)

    Not yet recruiting
    • Multiple Sclerosis
    • (no location specified)
    Jun 21, 2023

    Relaxin in Multiple Sclerosis (MS)

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Blood Draw
    • Lumbar Puncture
    • Portland, Oregon
      Providence MS Center
    Feb 2, 2022

    Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

    Completed
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
    • 18F-DPA-714 and 18F-FDG
    • Paris, France
    • +1 more
    Sep 14, 2022

    Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome Trial in Hamburg (Understanding MRI in

    Active, not recruiting
    • Multiple Sclerosis
    • +2 more
    • Understanding MRI in MS (website)
    • Control website
    • Hamburg, Germany
      University Medical Centre Hamburg-Eppendorf
    Dec 5, 2022

    Multiple Sclerosis Trial (Fecal Microbial Transplants)

    Not yet recruiting
    • Multiple Sclerosis
    • Fecal Microbial Transplants
    • (no location specified)
    Oct 24, 2022

    Mechanistic Studies of Teriflunomide in RRMS

    Active, not recruiting
    • Relapsing Remitting Multiple Sclerosis
    • Ann Arbor, Michigan
      University of Michigan
    Jul 27, 2022

    Cladribine Tablets in Highly-active Relapsing Multiple Sclerosis

    Recruiting
    • Relapsing-Remitting Multiple Sclerosis
      • Coventry, United Kingdom
      • +7 more
      May 20, 2022

      Multiple Sclerosis, Relapsing-Remitting Trial in Omaha (BrainHQ cognitive training, BrainHQ control games)

      Not yet recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • BrainHQ cognitive training
      • BrainHQ control games
      • Omaha, Nebraska
        University of Nebraska Medical Center
      Apr 22, 2022

      Multiple Sclerosis (MS) Symptoms

      Recruiting
      • Relapsing Remitting Multiple Sclerosis
        • Louisville, Kentucky
          University of Louisville (recruiting nationwide)
        Dec 13, 2021

        Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis Trial in United States (ANK-700, Placebo)

        Recruiting
        • Multiple Sclerosis (MS)
        • Relapsing Remitting Multiple Sclerosis
        • Cullman, Alabama
        • +14 more
        Dec 13, 2022

        Multiple Sclerosis, Relapsing-Remitting Trial in Chisinau (IMCY-0141, Placebo, Dimethyl Fumarate)

        Recruiting
        • Multiple Sclerosis, Relapsing-Remitting
        • Chisinau, Moldova, Republic of
          Republican Clinical Hospital, ARENSIA Exploratory Medicine
        Jun 8, 2022

        Relapsing-Remitting Multiple Sclerosis Trial in Columbus (Step Tracking, Water Tracking)

        Active, not recruiting
        • Relapsing-Remitting Multiple Sclerosis
        • Step Tracking
        • Water Tracking
        • Columbus, Ohio
          Department of Psychology, The Ohio State University
        Jan 24, 2022

        Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

        Recruiting
        • Relapsing Multiple Sclerosis
        • +2 more
        • Autologous Hematopoietic Stem Cell Transplantation
        • Best Available Therapy (BAT)
        • Palo Alto, California
        • +20 more
        Jan 25, 2023

        Relapsing-remitting Multiple Sclerosis Trial in Stockholm (Rituximab)

        Active, not recruiting
        • Relapsing-remitting Multiple Sclerosis
        • Stockholm, Sweden
          Fredrik Piehl
        Apr 8, 2022

        Multiple Sclerosis, Relapsing-Remitting Trial in Yvoir (Multiparametric assessment)

        Recruiting
        • Multiple Sclerosis, Relapsing-Remitting
        • Multiparametric assessment
        • Yvoir, Namur, Belgium
          CHU UCL Namur site Godinne
        Aug 19, 2022